Le ribosome - Un nouvel acteur de la tumorigenèse ?

Virginie Marcel; Frédéric Catez; Hichem C. Mertani; Jean-Jacques Diaz

doi:10.1051/medsci/20143001006

Accueil

Tous les numéros

Volume 30 / Numéro 1 (Janvier 2014)

Med Sci (Paris), 30 1 (2014) 21-24

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 30, Numéro 1, Janvier 2014


Page(s)		21 - 24
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/20143001006
Publié en ligne		24 janvier 2014

Romby P, Marzi S, Westhof E. La structure atomique du ribosome en pleine lumière. Med Sci (Paris) 2009 ; 25 : 977–981. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Melnikov S, Ben-Shem A, Garreau de Loubresse N, et al. One core, two shells : bacterial and eukaryotic ribosomes. Nat Struct Mol Biol 2012 ; 19 : 560–567. [CrossRef] [PubMed] [Google Scholar]
Jackson RJ, Hellen CUT, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010 ; 10 : 113–127. [CrossRef] [Google Scholar]
Ruggero D., Translational control in cancer etiology. Cold Spring Harb Perspect Biol 2013 ; 5 : a012336. [CrossRef] [PubMed] [Google Scholar]
Delloye-Bourgeois C, Goldschneider D, Paradisi A, et al. Nucleolar localization of a Netrin-1 isoform enhances tumor cell proliferation. Sci Signal 2012 ; 5 : ra57. [CrossRef] [PubMed] [Google Scholar]
Aguissa-Touré A, Da Costa, Leblanc T, et al. Anémie de Diamond-Blackfan. Med Sci (Paris) 2009 ; 25 : 69–76. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Hoareau-Aveilla C, Henry Y, Leblanc T. La dyskératose congénitale. Med Sci (Paris) 2008 ; 24 : 390–398. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Xue S, Barna M. Specialized ribosomes : a new frontier in gene regulation and organismal biology. Nat Rev Mol Cell Biol 2012 ; 13 : 355–369. [CrossRef] [PubMed] [Google Scholar]
Jack K, Bellodi C, Landry DM, et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol Cell 2011 ; 44 : 660–666. [CrossRef] [PubMed] [Google Scholar]
Belin S, Beghin A, Solano-Gonzàlez E, et al. Dysregulation of ribosome biogenesis translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 2009 ; 4 : e7147. [CrossRef] [PubMed] [Google Scholar]
Marcel V, Ghayad SE, Belin S, et al. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 2013 ; 24 : 318–330. [CrossRef] [PubMed] [Google Scholar]
Bywater MJ, Poortinga G, Sanij E, et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012 ; 22 : 51–65. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Romby P, Marzi S, Westhof E. La structure atomique du ribosome en pleine lumière. Med Sci (Paris) 2009 ; 25 : 977–981. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

[2] Melnikov S, Ben-Shem A, Garreau de Loubresse N, et al. One core, two shells : bacterial and eukaryotic ribosomes. Nat Struct Mol Biol 2012 ; 19 : 560–567. [CrossRef] [PubMed] [Google Scholar]

[3] Jackson RJ, Hellen CUT, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010 ; 10 : 113–127. [CrossRef] [Google Scholar]

[4] Ruggero D., Translational control in cancer etiology. Cold Spring Harb Perspect Biol 2013 ; 5 : a012336. [CrossRef] [PubMed] [Google Scholar]

[5] Delloye-Bourgeois C, Goldschneider D, Paradisi A, et al. Nucleolar localization of a Netrin-1 isoform enhances tumor cell proliferation. Sci Signal 2012 ; 5 : ra57. [CrossRef] [PubMed] [Google Scholar]

[6] Aguissa-Touré A, Da Costa, Leblanc T, et al. Anémie de Diamond-Blackfan. Med Sci (Paris) 2009 ; 25 : 69–76. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

[7] Hoareau-Aveilla C, Henry Y, Leblanc T. La dyskératose congénitale. Med Sci (Paris) 2008 ; 24 : 390–398. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

[8] Xue S, Barna M. Specialized ribosomes : a new frontier in gene regulation and organismal biology. Nat Rev Mol Cell Biol 2012 ; 13 : 355–369. [CrossRef] [PubMed] [Google Scholar]

[9] Jack K, Bellodi C, Landry DM, et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol Cell 2011 ; 44 : 660–666. [CrossRef] [PubMed] [Google Scholar]

[10] Belin S, Beghin A, Solano-Gonzàlez E, et al. Dysregulation of ribosome biogenesis translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 2009 ; 4 : e7147. [CrossRef] [PubMed] [Google Scholar]

[11] Marcel V, Ghayad SE, Belin S, et al. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 2013 ; 24 : 318–330. [CrossRef] [PubMed] [Google Scholar]

[12] Bywater MJ, Poortinga G, Sanij E, et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012 ; 22 : 51–65. [CrossRef] [PubMed] [Google Scholar]